Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms

Blood. 2019 Apr 4;133(14):1607-1610. doi: 10.1182/blood-2018-12-893917. Epub 2019 Jan 29.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor / analysis*
  • DNA Mutational Analysis
  • Histiocytic Disorders, Malignant / diagnosis
  • Histiocytic Disorders, Malignant / genetics
  • Histiocytic Disorders, Malignant / therapy*
  • Humans
  • Immunotherapy*
  • Mutation*
  • Prognosis
  • Tumor Burden

Substances

  • Biomarkers, Tumor